CXCR2 and cancer: The cancer cell-derived EV were shown to modulate the dissemination pattern of metastatic cells [43] and, in particular, MSC-EV have been seen to stimulate chondrocyte and synovial MSC migration via the CXCL5 and CXCL6/CXCR2 axes [12].